|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1996-10-11
|
|
pubmed:abstractText |
Chronic hepatitis C may lead to cirrhosis and hepatocellular carcinoma in a subset of patients. Because response rates with interferon alfa therapy are unsatisfactory, new therapies are needed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23 Suppl 2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
8-12
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8720287-Adult,
pubmed-meshheading:8720287-Antiviral Agents,
pubmed-meshheading:8720287-Aspartate Aminotransferases,
pubmed-meshheading:8720287-Drug Therapy, Combination,
pubmed-meshheading:8720287-Hepacivirus,
pubmed-meshheading:8720287-Hepatitis C,
pubmed-meshheading:8720287-Humans,
pubmed-meshheading:8720287-Interferon Type I,
pubmed-meshheading:8720287-Recombinant Proteins,
pubmed-meshheading:8720287-Reference Values,
pubmed-meshheading:8720287-Ribavirin
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
|
|
pubmed:affiliation |
Clinica Medica 2, University of Padova, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
